chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Higher cholesterol for no reason. Was fine before I took the vaccine between levels of 17-21. Now my doctor noticed the jump in November to 23. I went to check it again about 2 months later and it was reading that it was even higher at 43.  Doctor just put me on a new medication last week called Lipitor.
Patient given COVID-19 Moderna vaccine at age of 14 years old. Pharmacist (myself) realized patient was under the age of 18 years after administering the vaccine.
Given expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable. No concomitant product use was provided by the reporter. No treatment medication was provided.
Moderate local reaction with erythema and swelling ~8.5x7cm (left deltoid)
Onset of symptoms > 12hr <24hrs after receiving INFUENZA vaccine  (seasonal 2009 - 2010). Numbness and pain Rt ulnar distraction including mild edema of arm, wrist and hand.
Approximately 25 mins post Moderna COVID-19 vaccination, pt had bilateral hand swelling and her throat started to fell scratchy.   50mg IM Benadryl administered in R arm within 1 minute. Pt has no difficulty breathing, no urticaria, hives, redness or visible swelling on chest, face, or neck.  Post Benadryl administration, pt  has no difficulty breathing, difficulty swallowing, and hand swelling is decreasing.  Pt states she feels slightly dizzy and was briefly nauseous after Benadryl admin.  Pt wants to refuse.  EMS called a medical center for high-risk refusal and a doctor gave permission to refuse.  Pt's husband is driving pt home and will monitor pt for next 24 hours.  EMS also called Poison Control, who said there's nothing they can or will do. Our Medical Director was consulted and advised EMS to patch for HRR and to have pt follow up with an immunologist/allergist before receiving dose 2 of Moderna V+COVID-19 vaccination.  Our EMS Chief will be following up with the patient later today.
Immediate itching/elbow sensitive. Called Dr RX Benadryl/Ibuporfen for pain.
On 07/15/2022 at around 03:00PM I began to experience some diarrhea and was really tired. I felt like I needed to lie down, so I did and I ended up sleeping for around 2 hours. The next day, the same thing happened. After being out and about, I came home and had to sleep for another 2 hours. My wife went out to get an at home COVID-19 test which I took that afternoon 07/16 which was positive. I waited 24 hours and took another which was also positive. I began treating my symptoms of runny nose, cough, and body aches with NYQUIL. On Monday, I called my doctor who prescribed an antibiotic, azithromycin. They also advised that I take MUCINEX which I have started. I am still experiencing cold like symptoms but my body aches have gotten a bit better.
After receiving vaccine, patient was cautioned to sit in waiting are for the usual 15 mins, where he seemed normal and had family member in vicinity. ~ 10 minutes later a loud thud was heard and on observation patient was seen arising from floor with his girlfriend by his side.  Practitioner asked if he was ok and he replied he was fine.  Ice pack and Gatorade was offered to which he accepted.  He was further observed for another 15 minutes and left in good condition
1JUN91 rash on face, inc spitting up of formula, no temp; 8JUN91 sz grand mal; ambulance to ER hosp; focal sz;
a 5-11year old Pfizer Bivalent was administered to an 11year old patient, there was no adverse reaction (symptoms, signs)
-received 2nd booster on date above - reactions were swollen, painful lymph nodes in armpit of injection arm, yeast infection (no other explanation for getting one).I did contact my doctor to confirm lymph nodes was a side effect of shot and to get yeast infection prescription (OTC didnt work) - came down with covid a week later. was sick with symptoms for 2 weeks (out of work) (chest congestion, cough, some nasal congestion, exhausted) (no fever) and I am still experiencing shortness of breath/get winded very easily and large increase sleep apnea symptoms (very loud snoring, gasping for air while sleeping). the lingering symptoms from covid are what I have contacted my doctor for and seeking medical care for.
c/o body aches, fever, headache. Feeling weak. Increased redness with streaking to axilla; tender node.
Sharp stabbing pain to head, harp stabbing pain throughout body, Sharp Stabbing Pain ion top of right hand, Stiffness in joints, Dizziness when standing , including loss of balance, sharp stabbing pain under left knee, couldn't hardly lift left foot to put sock on, injection site was sore Fatigue, muscle pain, joint pain, chills, headache-all lasted til 01/13/2022 Did not see Dr. but have an appt in February and will share this with him then.
Unknown cause of death; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Unknown cause of death) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 948548) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on 01-Nov-2021 The patient died on 01-Nov-2021. The cause of death was not reported. It is unknown if an autopsy was performed. Not Provided          No treatment drug information provided. No concomitant drug information provided.  Company comment: This case concerns a patient with unknown age  and gender, with no reported medical history , who experienced Serious , unexpected event of Death, which occurred on Nov , 1, 2021 with an unknown dose number of mRNA-1273 Vaccine (Moderna Covid 19 Vaccine). The cause of death is unknown and it is also unknown if an autopsy was done . The re-challenge for this case is not applicable. The benefit -risk relationship of mRNA-1273 vaccine (moderna Covid 19 vaccine ) is not affected by this report.; Sender's Comments: This case concerns a patient with unknown age  and gender, with no reported medical history , who experienced Serious , unexpected event of Death, which occurred on Nov , 1, 2021 with an unknown dose number of mRNA-1273 Vaccine (Moderna Covid 19 Vaccine). The cause of death is unknown and it is also unknown if an autopsy was done . The re-challenge for this case is not applicable. The benefit -risk relationship of mRNA-1273 vaccine (moderna Covid 19 vaccine ) is not affected by this report.; Reported Cause(s) of Death: unknown cause of death
1/2 dollar size ecchymotic indurated lesion;dx cellulitis;Keflex given;
Started with fever 1 AM on 7/8/03 and noticed swelling and redness of left upper arm approx 2" x 3" in size.
Extreme nerve pain in upper shoulder down left arm including rash on left arm resulting in emergency room visit. Diagnoses: Herpes zoster without complication; adverse effect of COVID-19 vaccine.
for Cellulitis right upper arm with sepsis secondary to the cellulitis; for Cellulitis right upper arm with sepsis secondary to the cellulitis; severe yeast infection of the genitals and groin area related to the antibiotic therapy; Indication: asthma; white blood cell count over 30,000 during her hospital stay; redness of the right upper arm; This spontaneous report was received from a physician assistant and refers to a 30-year-old female patient. The patient's pertinent medical history included asthma. Her concomitant therapies included unspecified asthma medication. The patient did not have any drug reactions or allergies.  On 25-NOV-2019 the patient was vaccinated with a first dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) injection, intramuscularly in her right upper arm (lot # S018140 has been verified to be a valid lot number, expiration date 02-MAR-2021; exact dose was not reported) for asthma (unapproved indication).  On an unknown date in November 2019, the patient developed a cellulitis of right upper arm with sepsis secondary to the cellulitis and was admitted to the hospital because of the events on 27-NOV-2019. The patient was given unspecified antibiotics, which did not improve her condition and subsequently she was put on therapy with vancomycin (formulation, strength, dose, frequency, route of administration, lot # and expiration date were not reported). On an unknown date in November 2019 (reported as during hospital stay), the patient's white blood cell count was over 30000 (units not provided). Additionally, the reporter informed that the patient had unspecified hospital lab work and complete blood count performed, however the results were not provided.  On 29-NOV-2019, while on therapy with vancomycin, the patient was discharged from the hospital. On 02-DEC-2019, the patient was seen by the physician assistant for a hospital follow up visit with residual redness of the right upper arm.  Subsequently, the patient developed a severe yeast infection of the genitals and groin area related to the antibiotic therapy and was seen by a physician on 11-DEC-2019.  The outcome of the events was reported as recovering as the patient was not fully recovered at the time of the report.  The causality assessment between the events and the pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) was not provided.  The reporter considered the event infection (yeast infection) to be very serious (medically significant), as it could have become life threatening. Upon internal review, the events cellulitis of upper arm and sepsis secondary to the cellulitis were determined to be medically significant.
rash measured 9 CM long / was two inches below the injection site; had a bruise at the injection site; she awoke with redness; rash was flat and not raised but was warm / rash was warm and hot pink; rash was a little blotchy; This case was reported by a pharmacist via call center representative and described the occurrence of injection site rash in a 63-year-old female patient who received Herpes zoster (Shingrix) (batch number XN4FP, expiry date 19th March 2022) for prophylaxis.   On 24th February 2020, the patient received the 1st dose of Shingrix (intramuscular). On 29th February 2020, 5 days after receiving Shingrix, the patient experienced injection site rash, injection site bruising, erythema, skin warm and blotchy. On an unknown date, the outcome of the injection site rash was recovering/resolving and the outcome of the injection site bruising, erythema, skin warm and blotchy were unknown.   It was unknown if the reporter considered the injection site rash, injection site bruising, erythema, skin warm and blotchy to be related to Shingrix.  Additional information was provided as follows: The patient woke with redness that was two inches below the injection site and to the left. The rash measured 9 centimetre long and was flat and not raised but was warm and a little blotchy.  The patient claimed that the rash was warm and hot pink. The patient also had a bruise at the injection site. The reporter consented to follow up. This case had been linked with US2019169152, reported by same reporter.
Chills, fever,headache lasting 7days after second shot. Arm swelling, itching,rash 7days after first shot
This spontaneous report as received from medical assistant via a physician refers to a unspecified amount of patients of unknown age and gender. The patient's medical history, concurrent condition and concomitant medications were not reported. On an unknown date the patient were vaccinated with improperly stored GARDASIL 9 (lot M044717, expiration date 19-JUL-2019; lot N004799, expiration date 15-NOV-2019) for prophylaxis. Temperature was reported as 47°F to 77°F and Time frame was reported as 2 Hours 30 Minutes. Previous temperature excursion was involved. The call was because of a "data logger". No adverse effects reported. No PQC involved. No further details provided. This is one of the several reports linked via same reporter link. Sender's Comments: US-009507513-1708USA006277: US-009507513-1708USA005419.
small bumps covering arm of injection site as well as torso and spreading to other arm. Bump went from wrist to shoulder and from navel to neck. did not go away until i covered myself in cortizone 10 and took benedryl for 5-7 days
Child was injected with adult dosage of covid 19 pfizer booster shot. Experienced chest pain, shortness of breath, dizziness, nausea and vomiting. Arm pain.
Patient was administered vaccine. While waiting 15 min, patient became unresponsive and extremely pale.  I called EMS.  Administered one dose of epinephrine 0.3mg . Patient became responsive. After taking vitals, the EMS said pulse was low and recommended going to hospital.
Patient complained of feeling dizzy.  He appeared diaphoretic and vomited. Stated he had no ate anything for breakfast besides milk this morning.  Vitals: BP 110/70, HR 60s, 98% O2 stats.  Glucose 96  BP 120/80  Patient laid down, ate a snack and drink water/soda. Symptoms improved.  Discharged after 30 mins of observation.
Patient reported having a fever of 101.7 degrees with chills, abdominal cramps, vomiting, blurred vision, dizziness, laryngitis/hoarseness of voice, and headache. She described being awake intermittently throughout the night with these symptoms which continued into the next morning. She was seen at urgent care facility (UC) late that afternoon (on 11/12/20) for these symptoms and also to be tested for COVID-19 because of her fever. Rapid COVID antigen test was negative. Her fever resolved earlier that day & temperature measured 97.5 at UC. She reports UC told her to take Benedryl, which she did that evening upon reaching home. She reports feeling better a few hours after one dose of Benedryl. The following morning, 11/13/20, she reports feeling completely better with complete resolution of symptoms.
Fatigue, body aches, fever 100.7F, chills, headache  Treated with Tylenol
Area of right deltoid shows redness with erythmea, patient instructs very pain and warm to touch, instructed to apply cold compresses to site, use Benadryl and prescription of pain medication given if needed.
Intense aching in left testicle that began within an hour of receiving dose 2 of the vaccine; body aches; lethargy; headache; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 05May2021 at 15:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included Calcium/magnesium/zinc supplements and cannabis sativa (CANNABIS); all taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 14Apr2021 at 15:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 16:30, the patient experienced intense aching in left testicle that began within an hour of receiving dose 2 of the vaccine and lasted for roughly three days, The intensity of the pain fluctuated from 3/10 to 7/10, coming and going throughout the day, decreasing in frequency until it all but ceased on day 4. Since then he has had reoccurrences of the pain; however, they were momentary and few and far between maybe once or twice a day. His other side effects were normal headache, body aches and lethargy. The occurrences of testicular pain decreased alongside his other symptoms. The patient did not seek care because the experience seemed to correlate with the vaccine, and he thought it wise to wait it out. He did not or was not aware of having a pre-existing condition or testicular illness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense aching in left testicle that began within an hour of receiving dose 2 of the vaccine, body aches, lethargy and headache was resolving  at the time of this report.   No follow-up attempts are needed. No further information is expected.
right arm vaccination site. I felt a lot of nerve pain and got numb. It got worse. I saw the doctor and he said that it can be from the ingredients. Nothing seems to be working. Got on steroids and its hurting again.
Swelling around both ankles, itchy skin rash around ankles, which after 4hrs advanced to both calves and after 6hrs to both knees.  Rash was more severe on left leg.  Took 1 single dose of  diphenhyrdramine at 12 pm with little to no effect, took another single dose at 5pm and the rash seemed to stop advancing with less itchiness.
This spontaneous report was received from a immunization specialist concerning a 10 year old male patient. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were unknown by the reporter. On 08-MAY-2017, the patient was vaccinated with a dose of GARDASIL 9 lot # M036059, expiration date: 03-JUN-2019, as prophylaxis (Strength, dose and route were not reported). On 08-MAY-2017, after vaccination the patient laid down for 15 minutes. The patient then got lightheaded (dizziness), pale (pallor) and nausea at which time he laid down again with his legs elevated in the air. The patient was treated with oxygen, dextrose (+) electrolytes (unspecified)(PEDIALYTE) and crackers and felt better after 1 hour. It was unknown if lab diagnostics studies were performed to the patient. Immunization specialist requested lot check for this vaccine. The outcome of pallor, nausea and dizziness was unknown. The reporter did not provide the causality between the events and GARDASIL 9. Upon internal review the events pallor, nausea and dizziness were determined to be medically significant as they were treated with oxygen therapy that is considered medically significant.  Additional information has been requested.
I had a headache, I've had constant headaches, since I got that booster shot.; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (I had a headache, I've had constant headaches, since I got that booster shot.) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019F21A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (I had a headache, I've had constant headaches, since I got that booster shot.). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency; IBUPROFEN for Adverse event, at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (I had a headache, I've had constant headaches, since I got that booster shot.) had not resolved.            Concomitant product use was not provided by the reporter.
Pt recvd 3 doses of Engerix-B & exp a neg titer result p/the 3rd dose;
During monitoring Pt stated 7 mins after vaccination she started experiencing a burning feeling in her injected arm followed by systemic itching feeling 15 min after. She began to experience tingling feeling in her tongue followed by slight trouble swallowing (3/10 pt states). Medications Ordered/Given Per Protocol: Benadryl 25 mg IM Susequently - Pt denies: feeling flush, systemic itching, arm burning, tongue tingling, 1/10 tongue tingling, she is experiencing dry mouth. Patient to contact allergist after event. Has history of multiple allergies.
SORE ARM; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular) dose, start therapy date were not reported for prophylactic vaccination. The batch no was not known and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not reported. The outcome of sore arm was not reported. This report was non-serious.
Vaccine given too early. First vaccine done 12/27/21 second on 1/18/22. no adverse reaction  noted
was administered two expired doses; Drug dose administration interval too short; was administered two expired doses; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 51-year-old male patient who received HAB (Twinrix) (batch number 4F3YY, expiry date 01-JAN-2023) for prophylaxis.   Co-suspect products included HAB (Twinrix) (batch number 4F3YY, expiry date 01-JAN-2023) for prophylaxis.   On 17-FEB-2023, the patient received the 3rd dose of Twinrix. On 18-JAN-2023, the patient received the 2nd dose of Twinrix. On 18-JAN-2023, not applicable after receiving Twinrix and an unknown time after receiving Twinrix, the patient experienced expired vaccine used (Verbatim: was administered two expired doses). On 17-FEB-2023, the patient experienced expired vaccine used (Verbatim: was administered two expired doses) and drug dose administration interval too short (Verbatim: Drug dose administration interval too short). The outcome of the expired vaccine used, expired vaccine used and drug dose administration interval too short were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient:  US2023032762   Additional Information: GSK Receipt Date: 28-Feb-2023 Reporter's Comments:  Pharmacist reports a patient was administered two expired doses of Twinrix.  One dose was given on 18th Jan 2023 and one was given on 17th February 2023.  Both doses expired on 1st January 2023. The reporter consented to follow up via email. Additional Supportive Information: the patient received two doses of expired Twinrix vaccine on 18th January and 17th February 2023, earlier than the recommended schedule, which led to shortening of the vaccination schedule and expired vaccine used.; Sender's Comments:  US-GSK-US2023032762:same reporter - FU1 - deleted
patient c/o dizziness at 4:59pm.  V/S Bp 130/80  mmttg , 74 bpm 18 cpm 98% o2 SAT RA   #21 Pt stable and sent home